Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucagon-like peptide-1 receptor agonists and the risk of erectile dysfunction: a drug target Mendelian randomization study.

Frontiers in endocrinology - 1 Jan 2024

An Hongjin, Xie Kexin, Gan Huatian

Abstract excerpt

Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been widely used for type 2 diabetes (T2D) and weight management. However, the causal relationship of GLP-1RAs with erectile dysfunction (ED) was still unclear. Methods: Mendelian randomization (MR) analysis was conducted to reveal the association of genetically proxied GLP-1RAs with ED. The proportion of potential mediators mediating GLP-1RAs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 2
Share to Diabetes Treatment and Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erectile Dysfunction

Share to Glucagon-Like Peptide-1 Receptor

Share to Hypoglycemic Agents

Share to Mendelian Randomization Analysis

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 39605940
DOI: 10.3389/fendo.2024.1448394
PMCID: PMC11600104

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucagon-like peptide-1 receptor agonists and the risk of erectile dysfunction: a drug target Mendelian randomization study.PMID 39605940Read ↗

Type 2 diabetes mellitus increases risk of erectile dysfunction independent of obesity and dyslipidemia: A Mendelian randomization study.Semantic proximity Read ↗

Causal association between antidiabetic drugs and erectile dysfunction: evidence from Mendelian randomizationSemantic proximity Read ↗

Insights into modifiable risk factors of erectile dysfunction, a wide-angled Mendelian Randomization studySemantic proximity Read ↗

Effects of obesity-related anthropometric indices and body composition on erectile dysfunction mediated by coronary artery disease: A Mendelian randomization study.Semantic proximity Read ↗

[Nonalcoholic fatty liver disease and risk of erectile dysfunction: A bidirectional two-sample mendelian randomization study].Semantic proximity Read ↗

The association between lipid parameters and erectile dysfunction: a two-sample Mendelian randomization and case-control study.Semantic proximity Read ↗

Causal association of cardiovascular disease with erectile dysfunction: a two-sample bidirectional Mendelian randomization analysis.Semantic proximity Read ↗

Causal effects of Atorvastatin on the improvement of erectile dysfunction:A two-sample Mendelian randomization studySemantic proximity Read ↗

The association between serum 25-hydroxyvitamin D levels and erectile dysfunction: a two-sample Mendelian randomization analysis.Semantic proximity Read ↗

Genetically Proxied Therapeutic Effect of Metformin Use, Blood Pressure, and Hypertension's Risk: a Drug Target-Based Mendelian Randomization Study.Semantic proximity Read ↗

Effects of heart failure and coronary artery disease on erectile dysfunction: a two-sample Mendelian randomization studySemantic proximity Read ↗

Alzheimer's disease increases the risk of erectile dysfunction independent of cardiovascular diseases: A mendelian randomization study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.